CC BY
22
UDC 616.53-008-031.84
I.V. Odintsova, A.D. Diudiun
THE USE OF EXTEMPORAL DOSAGE FORM WITH PYROCTONE OLAMINE IN THE COMPLEX TREATMENT OF PATIENTS WITH SEBORRHEIC DERMATITIS
https://doi.org/m.26641/2307-0404.202LL228005
SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Skin and Venereal Diseases
V. Vernadsky str., 9, Dnipro, 49044, Ukraine
ДЗ «Днтропетровська медична академiя МОЗ Украти»
Кафедра шюрних та венеричних хвороб
(зав. - д.м.н. проф. А.Д. Дюдюн)
e-mail: inna_setrine@ukr.net
Цитування: Медичш перспективы. 2021. Т. 26, № 1. С. 191-196
Cited: Medicni perspektivi. 2021;26(1):191-196
Key words: seborrheic dermatitis, Malassezia spp., Complex treatment, pyrocton olamine Ключовi слова: себорейний дерматит, Malassezia spp., комплексне лiкування, троктон оламт Ключевые слова: себорейный дерматит, Malassezia spp., комплексное лечение, пироктон оламин
Abstract. The use of extemporal dosage form with pyroctone olamine in the complex treatment of patients with seborrheic dermatitis. Odintsova I.V., Diudiun A.D. The purpose of the work is to evaluate the efficacy and tolerance of extemporal dosage form with pyroctone olamine in the local treatment of patients with seborrheic dermatitis. Under our supervision there were 78 patients with seborrheic dermatitis aged 18 to 57 years. The average age of the patients was 29.5±2.1 years. Comprehensive treatment of patients with seborrheic dermatitis in both groups depended on the severity of clinical manifestations, the duration of the disease, and information on the effectiveness of previous therapy. For external treatment of the main group ofpatients with seborrheic dermatitis, an extemporaneously prepared gel with pyrocton olamine was used. Local treatment of patients in the comparison group consisted of the appointment of 1% cream of clotrimazole. An analysis of the results shows good therapeutic, microbiological effectiveness and good tolerance of extemporaneously prepared gel with pyrocton olamine in the complex treatment of patients with seborrheic dermatitis. The period for resolving the clinical manifestations of seborrheic dermatitis among patients in the main group was 2.5±0.1 days shorter compared with patients in the comparison group. The intensity of clinical manifestations in patients with seborrheic dermatitis of the main group decreased twice on the second day of complex treatment. In control patients with comparative seborrheic dermatitis, similar therapeutic efficacy was achieved on the fourth to fifth day. Long-term results of the study showed that the recurrence of the disease among patients of the main group was 5 (6.4%), and in patients of in the comparison group was 14 (17.9%). Clinical studies have shown good therapeutic efficacy and tolerance of the extemporal gel with pyroctone olamine in the complex treatment of patients with seborrheic dermatitis, which gives reason to recommend this dosage form for wider use in the practice of dermatovenerologists.
Реферат. Застосування eKcTeMnoparnHo'i лжарськоТ форми з шроктон оламшом у комплексному лшуванш хворих на себорейний дерматит. Одшцова 1.В., Дюдюн А.Д. Мета роботи - дати оцiнку ефективностi та переносимостi екстемпорально' лжарсько'' форми з троктон оламтом для мкцевого лiкування хворих на себорейний дерматит. Шд нашим спостереженням знаходилися 78 хворих на себорейний дерматит у вщ вiд 18 до 57 роюв. СереднШ вк пацieнтiв становив 29,5±2,1 року. Комплексне лiкування хворих на себорейний дерматит обох груп залежало вiд ступеня прояву клтчних симптомiв, тривалостi захворювання i вiдомостей про ефективтсть ратше проведеноi терапИ. Для зовншнього лкування основное групи хворих на себорейний дерматит застосовували екстемпорально приготований гель з троктон оламтом. Мкцеве л^вання хворих групи порiвняння складалося з призначення 1% крему клотримазол. Аналiз отриманих результатiв показуе хорошу терапевтичну, мiкробiологiчну ефективтсть i хорошу переносимкть екстемпорально приготованого гелю з троктон оламтом у комплексному лжувант хворих на себорейний дерматит. Перюд розршення ^тчних nроявiв себорейного дерматиту серед хворих основноi групи був на 2,5±0,1 дня коротше nорiвняно з хворими групи nорiвняння. 1нтенсивтсть miтчних nроявiв у хворих на себорейний дерматит основно' групи знизилась у два рази вже на другий день комплексного л^вання. У хворих на себорейний дерматит nорiвняльно'i групи досягти nодiбно'i терапевтично'1' ефективностi вдавалося на четвертий та п 'ятий день. Вiддаленi результати проведеного до^дження показали, що рецидив захворювання серед хворих основно'1' групи винику 5 (6,4%), а серед nацieнтiв групи nорiвняння - 14 (17,9%) nацieнтiв.
21/ Том XXVI/1
191
Висновки. Клтчне до^дження показало хорошу терапевтичну ефективтстъ i переносимктъ екстемпо-рального гелю з пiроктон оламiном у комплексному лiкуваннi хворих на себорейний дерматит, що дае пiдставу рекомендувати цю лiкарсъку форму для бшъш широкого застосування в практиц лiкарiв-дерматовенерологiв.
Seborrheic dermatitis is one of the most common chronic inflammatory diseases, accompanied by a change in the quantitative and qualitative sebum composition, which contributes to the impairment of microbial landscape of skin and activity of saprophytic microorganisms. In seborrheic dermatitis the pathological process in the form of erythematous-squamous rashes is localized on hairy part of the scalp and trunk which anatomically have a large number of sebaceous glands. The most frequent localization of the pathological process is the scalp, nasolabial folds, eyebrows, as well as skin of the chest and back. The seborrheic dermatitis incidence ranges from 1 to 3% of the total population and is diagnosed in more than 10% of dermatological patients [1, 6, 8, 14].
Clinical manifestations of seborrheic dermatitis are the appearance of well-defined erythematous-squamous rashes mainly on the scalp, often accompanied by various subjective sensations. With the disease progression, the pathological process covers the entire hairy part to the border with smooth skin [1, 4, 5, 12].
The cause and development mechanisms of seborrheic dermatitis are multifaceted and not completely studied. In modern literature, such mechanisms of occurrence and development of seborrheic dermatitis as genetic predisposition, the role of microbial agents, immune and endocrine disorders, pathological conditions of autonomic nervous system, gastrointestinal tract pathology, lipid metabolism disorders etc. are presented [1, 5, 7, 13].
One of the main pathogenetic mechanisms of seborrheic dermatitis is the Malassezia activation with the formation of complex microbial associations. Malassezia is a formation leader of fungi and microorganisms associations in the lesions with seborrheic dermatitis. Malassezia, in association with other bacteria, acquires an increased intrinsic virulence, which contributes to the increased virulence of other microorganisms. Formed fungi and microorganisms associations lead to an inflammatory process with the formation of various clinical manifestations of seborrheic dermatitis. The activation of opportunistic pathogenic microorganisms on the skin in seborrheic dermatitis is evidenced by the higher contamination frequency of the affected scalp areas with S. capitis, Micrococcus spp., Acinetobacter spp. etc. [6, 8, 9, 10].
Therefore, local treatment of seborrheic dermatitis should be directed to the use of dosage forms with antifungal and anti-inflammatory properties.
Complex treatment of seborrheic dermatitis should be aimed at eliminating disease signs, eliminating concomitant symptoms, especially patient's subjective feelings and maintaining long-term remission [4, 8, 11].
In this work, we set the following purpose: to evaluate the efficacy and tolerance of an extemporal dosage form with pyroctone olamine for the local treatment of patients with seborrheic dermatitis.
MATERIALS AND METHODS OF RESEARCH
Under our supervision there were 78 patients with seborrheic dermatitis aged 18 to 57 years. The average age of the patients was 29.5 years. Among the examined patients with seborrheic dermatitis, there were 53 men (67.9%), 25 women (32.1%).
The pathological process was localized only on hairy part of the scalp in 43 (55.1%) patients observed, and in 35 (44.9%) patients seborrheic process also spread to other skin areas. The duration of the disease ranged from 1 to 15 years.
All patients with seborrheic dermatitis, who were under our supervision, underwent the following examination methods: carefully collected disease anamnesis with taking into account patient's subjective feelings, skin examination, general and biochemical blood tests, general urinalysis [4].
The material for microscopic and bacteriological methods of the study were swabbings from the affected areas of the skin of patients with seborrheic dermatitis.
Patients were consulted by doctors of related specialties with the implementation of advisory recommendations.
The patients were divided into two similar groups - the main and the control.
The complex treatment of patients with sebor-rheic dermatitis in both groups depended on the severity of clinical manifestations, the disease duration, and information about the effectiveness of previous therapy. Antihistamines were prescribed for severe itching.
Local treatment in the comparison group consisted of the appointment of 1% clotrimazole cream.
For external treatment of the main group patients with seborrheic dermatitis, an extemporaneously prepared gel was used. The gel contains: pyroctone olamine (octopyrox) 1.0; demineralized naftalan 5.0; sodium carboxymethyl cellulose 3.0; glycerol 10.0; propylene glycol 20.0; tween 80 2.0; water (purified) up to 100.0 [8].
The analysis of the data received was carried out with application of the program product Statistica 6.1. (StatSoftlnc., serial N AGAR909E415822FA). The difference in indices with p<0.05 considered as probable one. To identify the relationships between the indices, Friedman's nonparametric variance analysis with the definition of X was used. The coupling between indices was considered significant if x2 value exceeded the critical one (x2=3.84) [2, 3].
RESULTS AND DISCUSSION
Among the examined patients with seborrheic dermatitis, in 45 (57.7%) patients oily seborrhea was revealed.
A mixed form of seborrheic dermatitis was revealed in 23 (29.5%) patients. It manifested itself in a moderate sebum secretion increase on the face and skin of the trunk with the appearance of separate comedones and acne-like rashes.
The dry form of seborrheic dermatitis was in 10 (12.8%) patients under our supervision. A dry form of seborrheic dermatitis was characterized by a sebum secretion decrease and the presence of scales of a different size and number. Most often, the pathological condition was developed in the occipital-temporal area, then it spread to the entire scalp surface. In our opinion, the low frequency of dry form of seborrheic dermatitis is due to the fact that patients with an insignificant clinical manifestation of the disease very rarely seek specialized medical care.
In most of the patients observed, a combination of several factors was established, such as the presence of foci of chronic infection, hormonal disorders (especially changes in the physiological balance of estrogens and androgens), vegetative-dystonic dysfunction, changes in the enzymatic activity of the organs of the gastrointestinal tract and liver, this creates conditions for which the body loses the ability to control the reproduction of yeastlike fungi and their virulence.
Seborrheic dermatitis most often begins during puberty. Dermatitis had a long course with frequent relapses, mainly in the autumn-winter period and was associated with the diet disorder. The duration of the dermatosis course in 29 cases (37.2%) was up to 6 years. In 49 (62.8%) patients observed, the seborrheic dermatitis course was more than 6 years. The disease occurence in 45 (57.7%) patients was associated with the onset of puberty. We could not indicate the cause of dermatosis in 33 (42.3%) patients. The patients described the disease occurrence as an increased skin oiliness and the periodic appearance of inflammatory elements in the seborrheic zones. The exacerbation of the pathological process was associated with the cold season as well as non-compliance with the diet or with the
nutrition peculiarities. A small amount of women observed associated the first manifestations of seborrheic dermatitis with the menstrual cycle formation.
Bacteriological and microscopic examination of the sampling material from the affected skin areas of seborrheic dermatitis patients revealed Malassezia spp. in 69 cases (88.5%).
The highest density of yeast-like fungi was on the skin in areas rich in sebaceous glands. These include the scalp, face, periauricular area, central areas of chest and back, genital area. Malassezia fungi prefer to colonize these areas due to their lipophilic properties. The Malassezia furfur species is unable to synthesize lipids, it needs an exogenous source of fatty acids, which are important both as an energy source and for metabolic processes, in particular membrane synthesis. The presence of saturated and unsaturated free fatty acids is necessary for the yeast-like Malassezia fungi full functioning. The main source of lipids for Malassezia spp. on human skin are triglycerides and free fatty acids produced by the sebaceous glands as well as cholesterol and cholesterol esters obtained in the process of kera-tinization and corneocytes destruction.
Among the causal mechanisms for the development of seborrheic dermatitis, an important role is played by the reproduction of opportunistic microorganisms against the background of an altered normal microbial biocenosis of the skin.
Among other microorganisms that were identified during the examination of our patients, one should point out: St. Capitis at 54 (79.5%), St. Epidermidis - 42 (53.8%), Micrococcus spp. 23 (29.5%), Acinetobacter spp. 12 (15.4%). St. Aureus, St. Capitis, St. Hominis, St. cohnii, St. Xylosus in the affected areas were found less (Fig. 1).
The complex treatment of most of the patients we observed was well tolerated. Adverse reactions were observed only in three patients with seborrheic dermatitis. Thus, two patients after applying 1% clotrimazole cream and one more after applying extemporal gel complained of the appearance of feeling of constriction and insignificant subjective sensations (of an indefinite nature) at the site of application of the local dosage form. The adverse reaction was unstable and resolved within 15-20 minutes without prescribing additional treatment. In the course of the treatment, there was a positive trend in the development of the pathological condition. However, a more pronounced therapeutic effect was found with the prescribing of an extemporal gel. Among the patients of the main group, the period of clinical manifestations resolution was by 2.5±0.1 days shorter than in the patients of the comparison group.
21/ Том XXVI/1
193
0 10 2Q 30 40 SO 60 70 50 30 100
Fig. 1. The frequency of detecting microorganisms in microbiological examinations (%)
Microscopic and bacteriological detection of Malassezia spp. from the affected skin areas of seborrheic dermatitis patients after local treatment was higher among patients of the comparison group. Thus, Malassezia spp. was found in 2 (5.1%) patients of the main and 9 (23.1%) of the control group. After the therapy of the affected skin areas,
%
other microorganisms were detected in 12 (15.4%) patients of the comparison and in 3 (3.9%) patients of the main group.
Long-term results of the study have shown that the disease recurrence among patients of the main group was in 5 cases (6.4%), among patients in the comparison group - in 14 (17.9%) (Fig. 2).
Fig. 2. Results of complex treatment of patients with seborrheic dermatitis (%)
Thus, the ongoing clinical study on the efficacy and tolerance of the extemporal gel for the local treatment of patients with seborrheic dermatitis has shown a good therapeutic effect, along with a good tolerance, in the complex treatment of the observed patients.
CONCLUSIONS
Considering a good therapeutic efficacy and tolerance of the extemporal gel with pyroctone olamine
in the complex treatment of patients with seborrheic dermatitis gives a good reason to recommend this dosage form for wider use in the practice of derma-tovenerologists.
Conflict of interests. The authors declare no conflict of interest.
REFERENCES
1. Albanova VI, Kalinina OV. [Seborrhea dermatitis of the scalp: the role of Malassezia]. Advances in medical mycology. 2016;14:11-14. Russian.
2. Antomonov MYu. [Mathematical processing and analysis of biomedical data]. 2017. p. 578 Russian.
3. Ivchenko GI, Medvedev Yul. [Introduction to Mathematical Statistics. "Statistics knows everything"]. URSS. 2017. p. 608. ISBN 978-5-9710-4535-9. Russian.
4. Kamyshnikov VS. [Clinical laboratory research methods]. MEDpress-inform; Kyiv. 2020;736:210. Russian.
5. Narozhna MV. [Rozladi intestinal microflora in patients with seborrheic dermatitis]. Dermatovenereology. Cosmetology. Sexopathology 2016;1-4:246-51. Ukrainian.
6. Odintsova IV, Dyudyun AD, Gladyshev VV, Polion NM. [Seborrheic dermatitis i Malassezia spp]. Dermatology and Venereology 2019;3:31-33. Ukrainian. doi: https://doi.org/10.33743/2308-1066-2019-3-31-33
7. Olisova OYu. [Pathogenesis and treatment of seborrheic dermatitis]. Dermatovenereology and dermato-cosmetology. 2016;1-2:38-42. Russian. Available from: https://www.umedp.ru/upload/iblock/97c/kelual.pdf.
8. Solodovnik SA, Gladyshev VV, Dyudyun AD, Lisyanskaya AP. [Preparation of ointments for rapid absorption of piroctone olamine with speech in the mind of a pharmacy. Information sheet]. 2019;210. Kyiv. Russian.
9. Sanders MGH, Pardo LM, Ginger RS, Kiefte-de Jong JC, Nijsten T. Association between diet and seborrheic dermatitis: A cross-sectional study. J Invest Dermatol. 2019;139:108-14.
doi: https://doi.org/10.1016/jjid.2018.07.027
10. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91:185-90. Available from: https://www.aafp.org/afp/2015/0201/p185.html
11. De Souza Leao Kamamoto C, Sanudo A, Has-sun KM, Bagatin E. Low dose oral isotretinoin for moderate to severe seborrhea and Seborrheic dermatitis: a randomized comparative. trial. Int J Dermatol 2017;56:80-85. doi: https://doi.org/10.1111/ijd.13408
12. Mameri ACA, Carneiro S, Mameri LMA, Telles da Cunha JM, Ramos-E-Silva M. History of seborrheic dermatitis: conceptual and clinico-pathologic evolution. Skinmed. 2017;15:187-94.
13. Karakadze MA, Hirt PA, Wikramanayake TC. The genetic basis of seborrheic dermatitis: a review. J Eur Acad Dermatol Venereol. 2018;32:529-36. doi: https://doi.org/10.1111/jdv. 14704
14. Moreno-Vázquez K, Calderón L, Bonifaz A Dermatitis seborreica. Actualización Dermatol Rev Mex. 2020;64(1):39-49. Available from: https://www.medi-graphic.com/pdfs/derrevmex/rmd-2020/rmd201f.pdf.
СПИСОК Л1ТЕРАТУРИ
1. Альбанова В. И., Калинина О. В. Себорейный дерматит волосистой части головы: роль Malassezia. Успехи медицинской микологии. 2016. № 14. С. 11-14.
2. Антомонов М. Ю. Математическая обработка и анализ биомедицинских данных, 2017. 578 с.
3. Ивченко Г. И., Медведев Ю. И. Введение в математическую статистику. Статистика знает все УРСС. 2017. 608 с. ISBN 978-5-9710-4535-9.
4. Камышников В. С. Клинические лабораторные методы исследования. Киев: МЕДпресс-информ, 2020. 736 с.
5. Нарожна М. В. Розлади микрофлоры кишечника у больных себорейным дерматитом. Дерматовенерология. Косметология. Сексопатология 2016. № 1-4. С. 246-251.
6. Одинцова И. В., Дюдюн А. Д., Глады-шев В. В., Полион Н. М. Себорейный дерматит b Malassezia spp. Дерматология и венерология. 2019.
№3. С. 31-33. DOI: https://doi.org/10.33743/2308-1066-2019-3-31-33
7. Олисова О. Ю. Патогенез и лечение себо-рейного дерматита. Дерматовенерология и дермато-косметология 2016. № 1-2. С. 38-42.
URL: https://www.umedp.ru/upload/iblock/97c/kelual.pdf
8. Солодовник С. А., Гладишев В. В., Дюдюн А. Д., Лисянська А. П. Приготування мазей для швидкого проникнення i3 дшчою речовиною пи-роктонного оламша в умовах аптеки. 1нф. лист № 210. Киев. 2019.
9. Association between diet and seborrheic dermatitis: A cross-sectional study / M. G. H. Sanders et al. J Invest Dermatol. 2019. Vol. 139. P. 108-114. DOI: https://doi.org/10.1016/jjid.2018.07.027
10. Clark G. W., Pope S. M., Jaboori K. A. Diagnosis and treatment of seborrheic dermatitis. Am
21/ Том XXVI/1
195
Fam Physician. 2015. Vol. 91. P. 185-190. URL: https://www.aafp.org/afp/2015/0201/p 185.html
11. De Souza Leao Kamamoto C., Sanudo A., Hassun K. M., Bagatin E. Low dose oral isotretinoin for moderate to severe seborrhea and Seborrheic dermatitis: a randomized comparative. trial. Int J Dermatol. 2017. Vol. 56. P. 80-85. DOI: https://doi.org/10.1111/ijd.13408
12. History of seborrheic dermatitis: conceptual and clinico-pathologic evolution / A. C. A. Mameri et al. Skinmed. 2017. Vol. 15. P. 187-194.
13. Karakadze M. A., Hirt P. A., Wikramanaya-ke T. C. The genetic basis of seborrheic dermatitis: a review. J Eur Acad Dermatol Venereol. 2018. Vol. 32. P. 529-36. DOI: https://doi.org/10.1111/jdv.14704
14. Moreno-Vázquez K., Calderón L., Bonifaz A. Dermatitis seborreica. Actualización Dermatol Rev Mex. 2020. enero-febrero. (Vol. 64, No. 1). P. 39-49. URL: https://www.medigraphic.com/pdfs/derrevmex/rmd -2020/rmd201f.pdf.
Crarra Hagmm^a go pegaKmi' 23.09.2020
♦
УДК 616-002.36-089.8-074:577.175.4 https://doi.org/10.26641/2307-0404.2021.1.228011
С.Д. Шаповал, ВИКОРИСТАННЯ ПРОКАЛЬЦИТОН1НУ
Л А Василевська У ХВОРИХ НА Х1РУРГ1ЧН1 ФОРМИ БЕШИХИ
ДЗ «Запоргзька медична академ1я п1слядипломно '1 освти МОЗ Укра'ши» 1нститут сепсису
бул. Вттера, 20, Запоргжжя, 69096, Украна
SI «Zaporizhzha Medical Academy ofpost-graduate education Ministry of Health of Ukraine» Institute of Sepsis
Wintera blvd., 20, Zaporizhzhia, 69096, Ukraine е-mail: adminzmapo@gmail.com
Цитування: Медичш перспективы. 2021. Т. 26, № 1. С. 196-200 Cited: Medicni perspektivi. 2021;26(1):196-200
Ключовi слова: прокальцитонт, хгрурггчнг форми бешихи Ключевые слова: прокальцитонин, хирургические формы рожи Key words: procalcitonin, surgical forms of erysipelas
Реферат. Использование прокальцитонина у больных с хирургическими формами рожи. Шаповал С.Д., Василевская Л.А. Идеальный маркер бактериальной инфекции должен не только давать возможность проводить раннюю диагностику, но и предоставлять информацию о ходе и прогнозе заболевания. На сегодняшний день наиболее хорошо изученным и достаточно широко применяемым в клинической практике является прокальцитонин (РСТ), но его значение при хирургических формах рожи недостаточно определено. Цель исследования: выяснить диагностическую и прогностическую значимость прокальцитонина у больных хирургических форм. Ретроспективно и проспективно проанализированы 114 историй болезней пациентов, которые находились на стационарном лечении в центре гнойно-септической хирургии КНП «Городская больница № 3» г. Запорожье за период 2019-2020 гг. Установлено, что наиболее часто очаг локализовался на нижних конечностях. В комплексном лечении больных рожей главное место принадлежит антибиотико-терапии (АБТ) и ранней хирургической обработке зоны патологического процесса. Определение уровня прокальцитонина в сыворотке крови дает возможность оценить прогресс и генерализацию процесса и является чувствительным тестом на эффективность проводимого лечения. Радикальное хирургическое вмешательство и своевременная направленная АБТ являются основными элементами успеха в лечении хирургических форм рожи и не подлежат пересмотру. В качестве диагностического маркера, который позволяет своевременно предусмотреть развитие сепсиса, является прокальцитонин.
